Medical Developments International | MVP - Operating Expenses


Medical Developments International reported AUD21.61M in Operating Expenses for its fiscal semester ending in December of 2025.





Operating Expenses Change Date
Akebia Therapeutics USD 63.08M 8.26M Dec/2025
Alaunos Therapeutics USD 1.19M 148K Sep/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Clinuvel Pharmaceuticals AUD 23.42M 6.49M Dec/2025
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Genetic Signatures AUD 17.52M 9.22M Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
Medical Developments International AUD 21.61M 11.59M Dec/2025
Neuren Pharmaceuticals AUD 25.23M 16.54M Dec/2025
Organon & Co USD 906M 362M Sep/2025
Paradigm Biopharmaceuticals AUD 21.85M 13.36M Dec/2025
PYC Therapeutics AUD 33.63M 14.33M Dec/2025
Starpharma Holdings AUD 11.7M 7.69M Dec/2025
Tectonic Therapeutic USD 21.52M 374K Dec/2025
Telix Pharmaceuticals AUD 405.4M 26.29M Dec/2025
Viatris USD 3.86B 335.7M Dec/2025
Xeris Pharmaceuticals USD 69.03M 1.38M Dec/2025